Results 121 to 128 of about 507,938 (128)

Clinical research progress and challenges of vaccine for human papillomavirus-associated cancers. [PDF]

Hum Vaccin Immunother
Xue L, Li X, Guo X, Xing H, Liu C.
europepmc   +1 more source

Productivity Improvement of Human Papillomavirus-like Particles in Insect Cells Using Hyper-Expression Baculovirus Vector. [PDF]

Vaccines (Basel)
Choi JB, Lee JH, Kim EH, Kim JD, Kim SY, Oh JM, Woo SD, Kim H, Han BK.   +8 more
europepmc   +1 more source

Immunopersistence of one or two doses of an Escherichia coli produced bivalent HPV vaccine. [PDF]

NPJ Vaccines
Liao M, Quan J, Zhu K, Hu X, Shen S, Xu J, Nie C, Xu W, Jiang H, Wu X, Zhong Y, Peng Y, Cai S, Chen J, Zhang C, Lin B, Su Y, Huang S, Chen Q, Wu T, Zhang J, Xia N.   +21 more
europepmc   +1 more source

HPV Vaccines - An Overview. [PDF]

Indian J Dermatol
Ghosh A, Chatterjee S, Dawn A, Das A.
europepmc   +1 more source

Virus Biomimetic-Delivery Systems for the Production of Vaccines. [PDF]

Biomimetics (Basel)
Barbinta-Patrascu ME, Negut I, Bita B.
europepmc   +1 more source

Towards Global HPV Eradication: Single-Dose HPV Vaccination vs. Pseudoscience. [PDF]

Pathophysiology
Shiro R, Tsunoda I.
europepmc   +1 more source

Bayesian hierarchical model predicts biopharmaceutical stability indicators and shelf life with application to multivalent human papillomavirus vaccine. [PDF]

Sci Rep
Ferrari F, Berger J, Lemieux L, Paduraru C, Dillon M, Liaw A, Carrillo R, Wong S, Salami H, Avalle P, Sherer E, Richardson D, Skomski D.   +12 more
europepmc   +1 more source